TG Therapeutics (TGTX) delivered earnings and revenue surprises of -50% and 4.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price increased by HC Wainwright from $49.00 to $55.00 in a report ...

CONTACT: Investor Relations Email: [email protected] Telephone: 1.877.575.TGTX (8489), Option 4 Media Relations: TG Therapeutics NewsMORE Related Stocks ...

Under the terms of the manufacturing supply agreement, FUJIFILM Diosynth Biotechnologies will provide secondary US-based ...

Weiss, chairman and chief executive officer of TG Therapeutics stated ... Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on ...